female sexual arousal disorder fsad disorder characterized persistent recurrent inability attain sexual arousal maintain arousal completion sexual activity diagnosis also refer inadequate lubricationswelling response normally present arousal sexual activity condition distinguished general loss interest sexual activity sexual dysfunctions orgasmic disorder anorgasmia hypoactive sexual desire disorder characterized lack absence sexual fantasies desire sexual activity period time although female sexual dysfunction currently contested diagnostic become common recent years use testosteronebased drugs offlabel treat fsad subtype female sexual dysfunction occurs distress due inability attain maintain adequate vaginal lubrication number studies explored factors contribute female sexual arousal disorder female orgasmic disorder factors include psychological physical factors psychologically possible causes disorder include impact childhood adolescence experiences current events within individual within current relationship little investigation impact individual factors female sexual dysfunction factors include stress levels fatigue gender identity health individual attributes experiences dysfunctional sexual may affect sexual desire response exposure pornographystyle media also thought lead poor body image selfconsciousness lowered verification individuals sexual activity disrupted overwhelming emotional distress resulting inability attain sexual pleasure sexual dysfunction also occur secondary major psychiatric disorders including substantial body research explored role interpersonal factors female sexual dysfunction particularly relation orgasmic response studies largely focused impact quality relationship sexual functioning partners studies evaluated role specific relationship variables whereas others examined overall relationship studies explored events others focused attitudes empirical measure relationship functioning subject populations varied distressed couples sexually dysfunctional clients satisfied relationships addition past experience personal psychology social context plays factor estimates percentage female sexual dysfunction attributable physical factors ranged disorders likely result sexual dysfunction lead problems circulatory neurological function factors extensively explored men women physical etiologies neurological cardiovascular illnesses directly implicated premature retarded ejaculation well erectile contribution physiological factors female sexual dysfunction clear however recent literature suggest may impairment arousal phase among diabetic women given diabetic women show significant variability response medical disorder surprising diseases influence arousal also highly variable fact lack clear association medical disorders sexual functioning suggests psychological factors play significant part impact disorders sexual kenneth maravilla professor radiology neurological surgery director mri research laboratory university washington seattle presented research findings based neuroimaging womens sexual function small pilot study four women female sexual arousal disorder maravilla reported less brain activation seen group including little activation amygdala women also showed increased activation temporal areas contrast women without sexual difficulties showed deactivation similar areas may suggest increased level inhibition arousal stimulus small group women fsad several types medications including selective serotonin reuptake inhibitors ssris cause sexual dysfunction case ssri snri dysfunctions may become permanent end one third post operation transgender women experience fsad roughly consistent menopause women hsdd transgender women largely caused lack testosterone especially gonads removed bottom surgery androgens produced smaller concentrations lower ovulating women progesterone shown alleviate symptoms hsdd transgender women well hormone kaplan proposed sexual dysfunction based intrapsychic interpersonal behavioural four factors identified could role development sexual dysfunction lack correct information regarding sexual social interaction unconscious guilt anxiety regarding sex performance anxiety failure communicate lists diagnostic criteria including minimum three dsmiv american psychiatric association diagnostic criteria marita p mccabe noted difficulties arise definition terms constitutes adequate lubricationswelling response gold standard regarding length time take become aroused level arousal achieved responses may vary one woman another dependent range factors include general mood sexual stimulation commences partners skill stimulating may also differences physiological subjective levels arousal women reporting feelings sexual arousal despite evidence vaginal vasocongestion others reporting arousal absence evidence expectations past experiences clinicians clients may also lead classify symptoms female sexual arousal disorder one woman several subtypes female sexual arousal disorders may indicate onset lifelong since birth acquired may based context may occur situations generalized situationspecific situational example disorder may occur spouse different partner length time disorder existed extent partner situationspecific opposed occurring situations may result different causative factors may influence treatment disorder may due psychological factors combination factors fda approved low sexual libido women one problem current definition dsmiv subjective arousal included often correlation womens subjective physiological mind recently fsad divided subtypes third subtype common clinical one criticism meaningful benefits experimental drugs womens sexual difficulties questionable financial conflicts interest experts endorse notion highly prevalent medical condition professor bioethics sociology jennifer r fishman argues categorization female sexual dysfunction treatable disease made possible input academic clinical researchers ethnographic research believes shown academic clinical researchers provided scientific research needed pharmaceutical companies biomedicalize female sexual dysfunction consequently identify market consumers questions professional ethics exchange network researchers pharmaceutical companies clinical research trials funded pharmaceutical companies researchers given considerable financial rewards work argues conferences definition disease diagnostic criteria defined research presented clinicians also ethically ambiguous also funded pharmaceutical heather hartely portland state university oregon critical shift female sexual dysfunction framed arousal problem desire problem article pinking viagra culture states change female sexual arousal disorder hypoactive sexual desire disorder indicative disease mongering tactics drug industry effort match drug subcomponent dsm additionally leonore tiefer nyu school medicine voiced concerns success viagra combination feminist rhetoric used means fasttracking public acceptance pharmaceutical treatment female sexual arousal disorder justification behind says branding viagra succeeded thoroughly rationalizing idea sexual correction enhancement pills seems inevitable fair product made available women giving dangerous appeal nonapproved drugs though offlabel behavioral treatments female sexual dysfunctions httpsenwikipediaorgwikifemalesexualarousaldisorder